Form 8-K - Current report:
SEC Accession No. 0001193125-23-067714
Filing Date
2023-03-10
Accepted
2023-03-10 17:01:00
Documents
12
Period of Report
2023-03-10
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K d483647d8k.htm   iXBRL 8-K 24272
  Complete submission text file 0001193125-23-067714.txt   145863

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA wve-20230310.xsd EX-101.SCH 2874
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20230310_lab.xml EX-101.LAB 17926
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20230310_pre.xml EX-101.PRE 11254
6 EXTRACTED XBRL INSTANCE DOCUMENT d483647d8k_htm.xml XML 3326
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37627 | Film No.: 23724546
SIC: 2834 Pharmaceutical Preparations